STOCK TITAN

Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Aurora Spine Corporation (ASG) to attend J.P. Morgan Healthcare Conference, President and CEO to present company's story to financial institutions and individuals
Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be attending the J.P. Morgan Healthcare Conference in San Francisco, CA the week of January 8-11, 2024. The conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. The company’s President and CEO, Trent Northcutt, will be presenting the Aurora story to several financial institutions and individuals.

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Chad Clouse
Chief Financial Officer
(760) 424-2004

www.aurora-spine.com                                


FAQ

What event is Aurora Spine Corporation attending?

Aurora Spine Corporation is attending the J.P. Morgan Healthcare Conference in San Francisco, CA.

When is the J.P. Morgan Healthcare Conference taking place?

The conference is scheduled for the week of January 8-11, 2024.

Who will be presenting the Aurora story at the conference?

The company’s President and CEO, Trent Northcutt, will be presenting the Aurora story to several financial institutions and individuals.

What is the ticker symbol for Aurora Spine Corporation?

The ticker symbol for Aurora Spine Corporation is ASG on the TSXV and ASAPF on the OTCQB.

AURORA SPINE CORP

OTC:ASAPF

ASAPF Rankings

ASAPF Latest News

ASAPF Stock Data

22.91M
57.32M
25.5%
0%
Medical Devices
Healthcare
Link
United States of America
Toronto